Aberrant promoter methylation and inactivation of PTEN gene in cervical carcinoma from Indian population

Journal of Cancer Research and Clinical Oncology

Volumn 137, Issue 8, 2011, Pages 1255-1262

  Rizvi, M Moshahid Alam ^a   Alam, M Shabbir ^a,b   Ali, Asgar ^a   Mehdi, Syed Jafar ^a   Batra, Swaraj ^c   Mandal, A K ^c  

^a JAMIA MILLIA ISLAMIA CENTRAL UNIVERSITY   (India)

^b JAZAN UNIVERSITY   (Saudi Arabia)

^c LNJP/MAMC Campus ^*  (India)

Author keywords

Cervical cancer; Immunohistochemistry; Methylation; PTEN

Indexed keywords

ADULT; ARTICLE; CANCER STAGING; CARCINOGENESIS; CONTROLLED STUDY; DNA METHYLATION; EXON; FEMALE; GENE; GENE EXPRESSION; GENE FUNCTION; GENE INACTIVATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INDIAN; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER METHYLATION; PTEN GENE; SINGLE STRAND CONFORMATION POLYMORPHISM; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX CARCINOMA;

ADENOCARCINOMA; ADULT; AGED; CARCINOMA, SQUAMOUS CELL; DNA METHYLATION; FEMALE; GENE SILENCING; HUMANS; IMMUNOHISTOCHEMISTRY; INDIA; MIDDLE AGED; NEOPLASM STAGING; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PROMOTER REGIONS, GENETIC; PTEN PHOSPHOHYDROLASE; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEINS; UTERINE CERVICAL NEOPLASMS;

EID: 79961166963     PISSN: 01715216     EISSN: 14321335     Source Type: Journal    
DOI: 10.1007/s00432-011-0994-0     Document Type: Article

References (35)

1. Alam MS, Rizvi MM (2011) Cancer of the uterine cervix and PTEN tumor suppressor gene. Lambert Academic Publishing, Germany
2. American Cancer Society (2009) Cancer facts & figures. American Cancer Society, Atlanta
3. JJ Aneta K Bozena G Cyprian N Urszula 2010 TP53 Mutations in Endometrial Cancers: Relation to PTEN Gene Defects Int J Gynecol Cancer 20 2 196 202 10.1111/IGC.0b013e3181c83675
4. JL Benedet H Bender H Jones III HYS Ngan S Pecorelli 2000 FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers Int J Gynecol Obstet 70 209 262 10.1016/S0020-7292(00)90001- 8 1:STN:280:DC%2BD3cvpsFegtQ%3D%3D
5. TH Cheung WK Lo SF Yim LK Chan MS Jeung CS Chan A Cheung TK Chung YF Wong 2004 Epigenetic and genetic alteration of PTEN in cervical neoplasm Gynecol Oncol 93 621 627 15196854 10.1016/j.ygyno.2004.03.013 1:CAS:528: DC%2BD2cXkvVeiu74%3D (Pubitemid 38766045)
6. Ferlay J, Bray F, Pisani P, Parkin DM (2004) GLOBOCAN 2002: cancer incidence, mortality and prevalence worldwide. In: IARC Cancer base No. 5, version 2.0. IARC Press, Lyon
7. IC Gray SM Phillips SJ Lee JP Neoptolemos J Weissenbach NK Spurr 1995 Loss of the chromosomal region 10q23-25 in prostate cancer Cancer Res 55 4800 4803 7585509 1:CAS:528:DyaK2MXptFKitbc%3D
8. P Guldberg P Straten A Birck V Ahrenkiel AF Kirkin J Zeuthen 1997 Disruption of the MMAC1/PTEN gene by deletion or mutation is a frequent event in malignant melanoma Cancer Res 57 3660 3663 9288767 1:CAS:528:DyaK2sXlvFentr8%3D (Pubitemid 27381203)
9. CY Guo XF Xu JY Wu SF Liu 2008 PCR-SSCP-DNA sequencing mrthod in detecting PTEN gene mutation and its significance in human gastric cancer World J Gastroenterol 14 24 3804 3811 18609703 10.3748/wjg.14.3804 1:CAS:528:DC%2BD1cXht1WlsrvK
10. JG Herman JR Graff S Myohanen BD Nelkin SB Baylin 1996 Methylation-specific PCR. A novel PCR assay for methylation status of CpG islands Proc Natl Acad Sci 93 9821 9826 8790415 10.1073/pnas.93.18.9821 1:CAS:528:DyaK28XlsFeht7Y%3D (Pubitemid 26296693)
11. J Huang CD Kontos 2002 PTEN modulates vascular endothelial growth factor-mediated signaling and angiogenic effects J Biol Chem 277 10760 10766 11784722 10.1074/jbc.M110219200 1:CAS:528:DC%2BD38Xis1Kht7w%3D (Pubitemid 34952828)
12. E Izycka-Swieszewska M Brzeskwiniewicz A Wozniak E Drozynska W Grajkowska D Perek A Balcerska T Klepacka J Limon 2010 EGFR, PIK3CA and PTEN gene status and their protein product expression in neuroblastic tumours Folia Neuropathol 48 4 238 245 21225506 1:CAS:528:DC%2BC3MXhs12jsr4%3D
13. ES Kandel J Skeen N Majewski A Di Cristofano PP Pandolfi CS Feliciano A Gartel N Hay 2002 Activation of Akt/protein kinase B overcomes a G (2)/m cell cycle checkpoint induced by DNA damage Mol Cell Biol 22 7831 7841 12391152 10.1128/MCB.22.22.7831-7841.2002 1:CAS:528:DC%2BD38XotlCgs7s%3D (Pubitemid 35217294)
14. YH Kang HS Lee WH Kim 2002 Promoter methylation and silencing of PTEN in gastric carcinoma Lab Invest 82 285 291 11896207 1:CAS:528:DC%2BD38XivFOltr0%3D
15. D Kong A Suzuki TT Zou A Sakurada LW Kemp S Wakatsuki T Yokoyama H Yamakawa T Furukawa M Sato N Ohuchi S Sato, et al. 1997 PTEN1 is frequently mutated in primary endometrial carcinomas Nat Genet 17 143 144 9326929 10.1038/ng1097-143 1:CAS:528:DyaK2sXmsFant74%3D
16. PA Lazo 1999 The molecular genetics of cervical carcinoma Br J Cancer 80 2008 2018 10471054 10.1038/sj.bjc.6690635 1:CAS:528:DyaK1MXlvVais7o%3D (Pubitemid 29391289)
17. J Li C Yen D Liaw, et al. 1997 PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer Science 275 1943 1947 9072974 10.1126/science.275.5308.1943 1:CAS:528:DyaK2sXit1Wgtbk%3D (Pubitemid 27148818)
18. G McConnachie I Pass SM Walker CP Downes 2003 Interfacial kinetic analysis of the tumour suppressor phosphatase, PTEN: evidence for activation by anionic phospholipids Biochem J 371 3 947 955 12534371 10.1042/BJ20021848 1:CAS:528:DC%2BD3sXjtFKls7o%3D (Pubitemid 36578893)
19. AB Mitra VS Murty RG Li M Pratap UK Luthra SK Chaganti 1994 Allelotype analysis of cervical carcinoma Cancer Res 54 4481 4487 8044799 1:CAS:528:DyaK2cXmt1OmtL0%3D (Pubitemid 24273166)
20. National Cancer Registry Programme (2007) Consolidated report of hospital based cancer registries 2001-2003. ICMR, New Delhi
21. DM Parkin F Bray J Ferlay P Pisani 2005 Global cancer statistics, 2002 CA Cancer J Clin 55 74 108 15761078 10.3322/canjclin.55.2.74 (Pubitemid 40372904)
22. Preacher KJ (2001) Calculation for the chi-square test: an interactive calculation tool for chi-square tests of goodness of fit and independence [Computer software]. Available from http://www.quantpsy.org
23. BK Rasheed TT Stenzel RE McLendon R Parsons AH Friedman HS Friedman DD Bigner SH Bigner 1997 PTEN gene mutations are seen in high-grade but not in low-grade gliomas Cancer Res 57 4187 4190 9331072 1:CAS:528:DyaK2sXmsFChtbg%3D (Pubitemid 27413420)
24. AHM Reid G Attard L Ambroisine G Fisher G Kovacs D Brewer J Clark P Flohr S Edwards DM Berney CS Foster A Fletcher WL Gerald H Møller VE Reuter PT Scardino J Cuzick JS de Bono CS Cooper 2010 Molecular characterisation of ERG, ETV1 and PTEN gene loci identifies patients at low and high risk of death from prostate cancer Br J Cancer 102 678 684 20104229 10.1038/sj.bjc.6605554 1:CAS:528:DC%2BC3cXitVWgtrw%3D
25. E Rhei L Kang F Bogomolniy MG Federici PI Borgen J Boyd 1997 Mutation analysis of the putative tumor suppressor gene PTEN/MMAC1 in primary breast carcinomas Cancer Res 57 3657 3659 9288766 1:CAS:528:DyaK2sXlvFentr4%3D (Pubitemid 27381202)
26. HB Salvesen N MacDonald A Ryan IJ Jacobs ED Lynch LA Akslen S Das 2001 PTEN methylation is associated with advanced stage and microsatellite instability in endometrial carcinoma Int J Cancer 91 22 26 11149415 10.1002/1097-0215(20010101)91:1<22::AID-IJC1002>3.0.CO;2-S 1:CAS:528:DC%2BD3cXovF2ht78%3D
27. Sambrook J, Russell DW (2001) Molecular Cloning: A Laboratory Manual, 3rd edn. Cold Spring Harbor Lab. Press, plainview
28. JC Soria HY Lee JI Lee L Wang JP Issa BL Kemp DD Liu JM Kurie L Mao F Khuri 2002 Lack of PTEN expression in non-small cell lung cancer could be related to promoter methylation Clin Cancer Res 8 1178 1184 12006535 1:CAS:528:DC%2BD38XksVWjsr8%3D (Pubitemid 34517656)
29. V Stambolic A Suzuki JL de la Pompa GM Brothers C Mirtsos T Sasaki J Ruland 1998 Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN Cell 95 29 39 9778245 10.1016/S0092-8674(00)81780-8 1:CAS:528:DyaK1cXmslWlsr0%3D (Pubitemid 28458022)
30. PA Steck MA Pershouse SA Jasser, et al. 1997 Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers Nat Genet 15 356 362 9090379 10.1038/ng0497-356 1:CAS:528:DyaK2sXitF2hs70%3D (Pubitemid 27147102)
31. JM Walboomers MV Jacobs MM Manos FX Bosch JA Kummer KV Shah, et al. 1999 Human papillomavirus is a necessary cause of invasive cervical cancer worldwide J Pathol 189 12 19 10451482 10.1002/(SICI)1096-9896(199909)189:1<12::AID- PATH431>3.0.CO;2-F 1:STN:280:DyaK1Mzot1CjsQ%3D%3D (Pubitemid 29406813)
32. YE Wang X Wu H Suzuki RE Reiter C Tran RL Vessella JW Said WB Isaacs CL Sawyers 1998 Inactivation of the tumor suppressor PTEN/MMAC1 in advanced human prostate cancer through loss of expression Proc Natl Acad Sci USA 95 5246 5250 10.1073/pnas.95.9.5246 (Pubitemid 28208583)
33. X Wu K Senechal MS Neshat YE Whang CL Sawyers 1998 The PTEN/MMAC1 tumor suppressor phosphatase functions as a negative regulator of the phosphoinositide 3-kinase/Akt pathway Proc Natl Acad Sci USA 95 15587 15591 9861013 10.1073/pnas.95.26.15587 1:CAS:528:DyaK1MXhvFejsQ%3D%3D (Pubitemid 29018743)
34. HJ Yang SW Liu Y Wang CK Tsang YS Ngan 2006 Differential DNA methylation profiles in gynecological cancers and correlation with clinic-pathological data BMC Cancer 6 212 16928264 10.1186/1471-2407-6-212 (Pubitemid 44382757)
35. L Zhang T Liu H Liu J Gao C Gu 2000 Loss and inactivation of PTEN/MMAC1/TEP1 gene in lung cancer Zhonghua Bing Li Xue Za Zhi 29 85 88 11866895 1:STN:280:DC%2BD387jt1eiug%3D%3D